Influenza Diagnostics Market is forecast to grow at a CAGR of 7.1%, reaching a market size of $1.46 billion by the year 2032

The global influenza diagnostics market is poised for significant growth, driven by the increasing prevalence of influenza, the need for rapid and accurate diagnosis, and the development of innovative testing technologies.

Market Overview

The global influenza diagnostics market size was valued at USD 0.79 billion in 2023 and is anticipated to grow from USD 0.84 billion in 2024 to USD 1.46 billion by 2032, exhibiting a CAGR of 7.1% during the forecast period. This growth reflects the increasing demand for rapid and accurate diagnostic tools to facilitate timely treatment and prevent the spread of influenza.

Some of the major players operating in the global influenza diagnostics market include:

Abbott Laboratories
Becton, Dickinson and Company (BD)
bioMérieux SA
Bio-Rad Laboratories, Inc.
CorisBioConcept
DiaSorin S.p.A.
F. Hoffmann-La Roche Ltd.
GenMark Diagnostics, Inc.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience, Inc.
Quidel Corporation
SA Scientific, Ltd.
Sekisui Diagnostics
Thermo Fisher Scientific Inc.

Key Market Drivers

Increasing Prevalence of Influenza: Influenza remains a significant public health concern worldwide, causing seasonal outbreaks and impacting millions of people annually.
Need for Rapid Diagnosis: Rapid and accurate diagnosis of influenza is crucial for timely initiation of antiviral treatment, which can significantly reduce the severity and duration of illness.
Advancements in Diagnostic Technologies: Advancements in diagnostic technologies, such as the development of rapid antigen tests (RATs), molecular tests (like PCR), and point-of-care (POC) tests, are improving the speed, accuracy, and accessibility of influenza diagnostics.
Importance of Pandemic Preparedness: The COVID-19 pandemic highlighted the importance of rapid and accurate diagnostic testing for respiratory infections, driving further innovation in influenza diagnostics.

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

Influenza Diagnostics Market, Regional Outlook (Revenue – USD Billion, 2019-2032)

North America
- Product Outlook
  - Instruments
  - Test Kit and Reagents
  - Others
- Test Type Outlook
  - RIDT
  - Cell Culture
  - RT-PCR
  - Others
- End Use Outlook
  - Hospitals
  - Diagnostic Laboratories
  - Others
Europe
- Product Outlook
  - Instruments
  - Test Kit and Reagents
  - Others
- Test Type Outlook
  - RIDT
  - Cell Culture
  - RT-PCR
  - Others
- End Use Outlook
  - Hospitals
  - Diagnostic Laboratories
  - Others

This section of the research report provides an analysis of the geographic landscape of the Influenza Diagnostics Market. It covers several aspects like industry share, gross margin and growth rate for all the major regions of the industry. By going through the regional analysis section, businesses can better understand the needs and wants of their target market. Also, it enables companies to make informed decisions about the products or services they’re providing. Furthermore, the research report provides an in-depth analysis of all the major sub-regions for a comprehensive understanding of the market.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:

https://www.polarismarketresearch.com/industry-analysis/influenza-diagnostics-market

Recent Developments:

BD’s CE Marking for BD MAX Respiratory Viral Panel: In June 2022, BD received CE marking for its BD MAX Respiratory Viral Panel (RVP), a molecular diagnostic test that can detect SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus (RSV). This multi-pathogen test can aid in the rapid and accurate diagnosis of respiratory infections.
Hologic’s FDA Clearance for Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay: In May 2023, Hologic Inc. received FDA clearance for its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay, enabling simultaneous detection of four common respiratory viruses. This multi-pathogen test can improve the efficiency and accuracy of respiratory virus testing.
Cue Health Secures BARDA Contract: In August 2023, Cue Health secured a contract from BARDA to develop a molecular multiplex test for Flu A/B, RSV, and COVID-19 for both over-the-counter (OTC) and point-of-care (POC) use. This development will enhance access to rapid and convenient testing for respiratory infections.

Table of Contents:

Global Influenza Diagnostics Market Insights
4.1. Influenza Diagnostics Market – End Use Snapshot
4.2. Influenza Diagnostics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing incidence of influenza is projected to spur product demand
4.2.1.2. Increasing adoption of point-of-care testing is expected to drive influenza diagnostics market growth
4.2.2. Restraints and Challenges
4.2.2.1. Regulatory challenges and compliance requirements are likely to impede the market growth
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Influenza Diagnostics Market End Use Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Influenza Diagnostics Market, by Test Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
5.3. RIDT
5.3.1. Global Influenza Diagnostics Market, by RIDT, by Region, 2019-2032 (USD Billion)
5.4. Cell Culture
5.4.1. Global Influenza Diagnostics Market, by Cell Culture, by Region, 2019-2032 (USD Billion)
5.5. RT-PCR
5.5.1. Global Influenza Diagnostics Market, by RT-PCR, by Region, 2019-2032 (USD Billion)
5.6. Others
5.6.1. Global Influenza Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

Conclusion:

The global influenza diagnostics market is poised for continued growth, driven by the ongoing need for rapid and accurate diagnostic tools to combat influenza and other respiratory infections. The development of innovative diagnostic technologies, such as multiplex tests and point-of-care devices, will play a crucial role in improving patient outcomes and public health surveillance.

More Trending Latest Reports By Polaris Market Research:

Frozen Food Market

Honey Wine Market

Car Wash Services Market

Underfloor Heating Market

Digital Transaction Management Market

Submarine Cables Market

Cyber Warfare Market

Complementary and Alternative Medicine for Anti-Aging & Longevity Market